Unknown

Dataset Information

0

Patient-specific iPSCs carrying an SFTPC mutation reveal the intrinsic alveolar epithelial dysfunction at the inception of interstitial lung disease.


ABSTRACT: Alveolar epithelial type 2 cell (AEC2) dysfunction is implicated in the pathogenesis of adult and pediatric interstitial lung disease (ILD), including idiopathic pulmonary fibrosis (IPF); however, identification of disease-initiating mechanisms has been impeded by inability to access primary AEC2s early on. Here, we present a human in vitro model permitting investigation of epithelial-intrinsic events culminating in AEC2 dysfunction, using patient-specific induced pluripotent stem cells (iPSCs) carrying an AEC2-exclusive disease-associated variant (SFTPCI73T). Comparing syngeneic mutant versus gene-corrected iPSCs after differentiation into AEC2s (iAEC2s), we find that mutant iAEC2s accumulate large amounts of misprocessed and mistrafficked pro-SFTPC protein, similar to in vivo changes, resulting in diminished AEC2 progenitor capacity, perturbed proteostasis, altered bioenergetic programs, time-dependent metabolic reprogramming, and nuclear factor κB (NF-κB) pathway activation. Treatment of SFTPCI73T-expressing iAEC2s with hydroxychloroquine, a medication used in pediatric ILD, aggravates the observed perturbations. Thus, iAEC2s provide a patient-specific preclinical platform for modeling the epithelial-intrinsic dysfunction at ILD inception.

SUBMITTER: Alysandratos KD 

PROVIDER: S-EPMC8432578 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC9360361 | biostudies-literature
| S-EPMC6118576 | biostudies-literature
| S-EPMC10568624 | biostudies-literature
| S-EPMC5023030 | biostudies-literature
| S-EPMC5033906 | biostudies-literature
| S-EPMC4242631 | biostudies-literature
| S-EPMC8533862 | biostudies-literature
| S-EPMC9434111 | biostudies-literature
| S-EPMC6483196 | biostudies-literature